http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2305558-C2
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e2aad5b718427160ac55874a995765bf http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a1bd001a3c0d80fd8a96df651647b078 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-02 |
| filingDate | 2004-12-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2007-09-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_22b2fb7f3af74325a778c892ad297f89 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_41d228a2d6751810524abf6b74357b7f |
| publicationDate | 2007-09-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | RU-2305558-C2 |
| titleOfInvention | Method of treating chronic diseases of ear-nose-throat organs with viral, bacterial, and mixed viral-bacterial etiology in hiv-infected children and adolescents |
| abstract | FIELD: pediatrics, otolaryngology, and infection diseases. n SUBSTANCE: treatment comprises determining level of secretory immunoglobulins sIgG and sIgA in saliva before administration of immunomodulator "IRS 19" and 7 days after administration. In case of increase of sIgA against reduction of sIgG, antibacterial therapy is not prescribed. If increase of sIgG is observed against reduction of sIgA or no changes in the latter, wide action spectrum antibiotics are prescribed in age-specific doses and in generally accepted administration schemes. n EFFECT: achieved long-term stable remission with minimum side effects. n 2 tbl, 2 ex |
| priorityDate | 2004-12-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 85.